Reformulary Group, an independent drug plan management company, has announced the establishment of its Cannabis Formular
Group plan members with high-cost chronic conditions drive almost 80 per cent of plan costs with an average annual drug
RBC Insurance is taking a two-pronged approach to helping its group benefits clients suffering from autoimmune illnesses
The CLHIA is raising concerns about the federal Standing Committee on Health’s report on pharmacare tabled yesterday whi
Anti-depressants are a finicky class of drugs that often take four tries to ensure a patient receives the right medicati
Empire Life has launched a new $7,500 ‘drug only’ pooling product, available as of today for new customers and at renewa
A new five-year initiative will see the pricing of nearly 70 of the most commonly prescribed drugs in Canada reduced by